Accessibility Menu

Bb Biotech Ag(FRA) BBZA

Market Cap€3.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-41%
5 Year-28%
1 Year+73%
1 Month+7%
€58.60
-2.01%
-1.20Today
Bb Biotech Ag last closing stock price
MetricPriceDate
Last closeEUR 59.402026-08-31
Bb Biotech Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.02%EUR 58.802026-08-24
1 month+7.41%EUR 55.302026-07-31
3 month+28.71%EUR 46.152026-06-02
Year to date+22.35%EUR 48.552025-12-30
1 year+73.43%EUR 34.252025-08-29
3 year+38.14%EUR 43.002023-09-01
5 year-27.65%EUR 82.102021-09-01
Since inception-41.45%EUR 102.141997-11-11

Bb Biotech Ag Financials at a Glance

Market Cap

€3.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€158.82

Net Income (TTM)

€1.45K

EPS (TTM)

€26.40

P/E Ratio

2.22

Dividend

€2.47

Beta (Volatility)

-0.05 (Low)

Price

€58.60

Volume

0

Open

€58.60

Previous Close

€58.60

Daily Range

€58.60 - €58.60

52-Week Range

€34.30 - €60.60

Estimated Earnings Date

N/A

BBZA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bb Biotech Ag

BB Biotech is an equity fund launched and managed by Bellevue Asset Management. It invests in the public equity markets across the globe. BB Biotech primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. It employs a fundamental analysis to create its portfolio. BB Biotech began operation on November 09, 1993. It has its headquarters in Schaffhausen in Switzerland.

Industry

Capital Markets

Sector

Financials

Website

www.bbbiotech.com

BBZA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

54.67%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

45.05%

Dividend Yield

4.21%

Payout Ratio

N/A

Stock Overview

Market Cap

€3.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

55.15M

Volume

0

Avg. Volume

463.773

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bb Biotech Ag Performance Analysis

Bb Biotech Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR -28,244,115N/A
20232023-12-31EUR -17,769,609-37.1%
20242024-12-31EUR 65,223,966N/A
20252025-12-31EUR 81,953,04125.6%
Bb Biotech Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -6.48-4.2%
20232023-12-31EUR -3.88-40.2%
20242024-12-31EUR 1.45N/A
20252025-12-31EUR 11.25674.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€119.73

-5.5%

Gross Profit

€101.04

N/A

Gross Margin

99.94%

N/A

Market Cap

€3.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

€490.94

-4.6%

EBITDA

€491.32

-4.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€220.94

+9466.4%

Total Debt

€0.00

N/A

Accounts Receivable

N/A

N/A

Inventory

€0.00

N/A

Long Term Debt

€0.00

N/A

Short Term Debt

€0.00

N/A

Return on Assets

54.59%

-2.8%

Return on Invested Capital

-1.90%

+0.8%

Free Cash Flow

-€165.13

+2.7%

Operating Cash Flow

-€165.13

+2.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About BBZA

What is the current price of Bb Biotech Ag?

Bb Biotech Ag is trading at €58.60 per share.

What is the 52-week range for Bb Biotech Ag?

Over the past 52 weeks, Bb Biotech Ag has traded between €34.30 and €60.60.

How much debt does Bb Biotech Ag have?

As of the most recent reporting period, Bb Biotech Ag reported total debt of €0.00.

How much cash does Bb Biotech Ag have on hand?

Bb Biotech Ag reported €220.94M in cash and cash equivalents in its most recent financial results.

What is Bb Biotech Ag’s dividend yield?

Bb Biotech Ag currently has a dividend yield of 4.21%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services